AVITA Medical, Inc. last reported quarterly results on Aug 6, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $21.5 million (+17.9% year over year) and diluted EPS of -$0.25. It usually reports 13–44 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 5, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Thursday. Based on last year's release for the same quarter on Nov 6, 2025. The company has not filed these results with the SEC yet. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 13–44 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 6, 2026
37 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
21
+17.9%
|
-8
+22.8%
|
-0.25
+34.2%
|
|
May 14, 2026
44 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
19
+4.0%
|
-11
+23.4%
|
-0.35
+34.0%
|
|
Jan 13, 2026
13 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
17
-4.3%
|
-12
-0.3%
|
-0.38
+13.7%
|
|
Nov 6, 2025
37 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
17
-12.9%
|
-13
+18.6%
|
-0.46
+25.8%
|
|
Aug 7, 2025
38 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
18
+20.0%
|
-10
+35.6%
|
-0.38
+36.7%
|
|
May 8, 2025
38 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
18
+65.0%
|
-14
+25.7%
|
-0.53
+27.4%
|
|
Jan 7, 2025
7 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
18
+28.3%
|
-12
-64.0%
|
-0.44
-59.8%
|
|
Nov 7, 2024
38 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
19
+42.1%
|
-16
-86.0%
|
-0.62
-82.4%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- RCEL (Nasdaq), AVHHL (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Valencia, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1762303
- Former names
- Avita Therapeutics, Inc. (until Dec 10, 2020); Avita Medical, Ltd. (until Jun 30, 2020)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.